The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Soteropoulos Paula since year 2005.
The trader's CIK number is 1692444.
At the time of the last reporting, Soteropoulos Paula was the Chief Executive Officer of Akcea Therapeutics, Inc. .
(stock ticker symbol AKCA).
See this page for all insider trading activities at Akcea Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-04-08||AKCA||Akcea Therapeutics, Inc.||Option Ex||1,787||6.48||11,579|
|2019-04-05||AKCA||Akcea Therapeutics, Inc.||Sale||30,000||32.11||963,300|
|2019-04-05||AKCA||Akcea Therapeutics, Inc.||Option Ex||30,000||6.48||194,400|
|2019-04-08||AKCA||Akcea Therapeutics, Inc.||Sale||1,787||32.17||57,480|
|2019-03-06||AKCA||Akcea Therapeutics, Inc.||Sale||18,386||32.14||590,852|
|2019-03-06||AKCA||Akcea Therapeutics, Inc.||Option Ex||18,386||6.48||119,141|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Soteropoulos Paula (Chief Executive Officer of Akcea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.